Ionis to present at upcoming investor conferences

Rhea-AI Summary

Ionis Pharmaceuticals (Nasdaq: IONS) has announced its participation in two upcoming investor conferences. The company's management will engage in fireside chats at the 2024 Wells Fargo Healthcare Conference on September 4, 2024, and the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024.

Investors and interested parties can access live webcasts of these presentations through the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays of the presentations will be available on the website within 48 hours and will be archived for a time, providing an opportunity for those unable to attend the live events to stay informed about the company's updates and strategies.

CARLSBAD, Calif., Aug. 28, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

• 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024
• Morgan Stanley 22^nd Annual Global Healthcare Conference on Thursday, September 5, 2024

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.

To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.

Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – ir@ionis.com – 760-603-2331

Ionis Pharmaceuticals Media Contact:
Hayley Soffer – media@ionis.com – 760-603-4679

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302232168.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

When is Ionis Pharmaceuticals (IONS) participating in the Wells Fargo Healthcare Conference?

Ionis Pharmaceuticals (IONS) is participating in the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024.

What investor conference is Ionis Pharmaceuticals (IONS) attending on September 5, 2024?

Ionis Pharmaceuticals (IONS) is attending the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024.

How can investors access the live webcasts of Ionis Pharmaceuticals' (IONS) investor conference presentations?

Investors can access the live webcasts of Ionis Pharmaceuticals' (IONS) presentations through the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events.

How long will the replays of Ionis Pharmaceuticals' (IONS) investor conference presentations be available?

Replays of Ionis Pharmaceuticals' (IONS) investor conference presentations will be available on the company's website within 48 hours and will be archived for a time.